Virtus Biotech ETF
16 hedge funds and large institutions have $3.28M invested in Virtus Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
78% more funds holding
Funds holding: 9 → 16 (+7)
61% more capital invested
Capital invested by funds: $2.04M → $3.28M (+$1.25M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$794K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$426K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$382K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$271K |
| 5 |
Jane Street
New York
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$45.3K |
BBP Hedge Fund Activity: Q3 2015 in Review
16 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q3 2015, worth a combined $3.28M — up 61% from $2.04M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BBP positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $794K. The largest seller was LPL Financial, cutting an estimated $45.3K.
- 16 institutional investors held Virtus Biotech ETF (BBP) as of Q3 2015, up from 9 in Q2 2015.
- Funds reported $3.28M of Virtus Biotech ETF stock for Q3 2015, up 61% quarter-over-quarter.
- 7 funds opened new Virtus Biotech ETF positions in Q3 2015 and 0 closed out, a net change of +7 holders.
- The largest Virtus Biotech ETF buyer in Q3 2015 was Virtu KCG Holdings, an estimated $794K added.
- The largest Virtus Biotech ETF seller in Q3 2015 was LPL Financial, an estimated $45.3K sold.
Based on aggregated 13F filings for Q3 2015.